The course is designed to provide a current review of the pathology and clinical aspects of pigmented and other skin tumours. Traditional and more recently recognised morphological features useful for diagnosis will be presented. New modern ancillary tests will be explained and their use discussed. Emphasis will be placed on clinic-pathological correlation as well as the integration of genetic and genomic findings for diagnosis, prognosis and treatment selection. Most of the topics will be addressed in lecture format.
At the end of the course cases of high didactic value (e.g., problematic melanocytic lesions with known outcome and/or genomic findings) will be discussed in detail.
- Know important morphological clues useful for the differential diagnosis of melanocytic and other skin tumours and understand the value as well as limitations of morphologic findings and clinical correlations.
- Be familiar with the spectrum of melanocytic naevi and melanoma variants.
- Understand the sensitivity and specificity of various novel methods (new immunohistochemical reagents, dermoscopy, cytogenetic and molecular tests) for the diagnosis of melanocytic tumours.
- Have a grasp of modern concepts in melanocyte pathology, with emphasis on pathological, genomic and genetic correlations
- Know what is relevant to report and communicate to clinicians.
- Comprehend the role of the pathologist in determining treatment options for the patient through molecular and immunohistochemical analysis.
The course will be of value to dermatopathologists, general pathologists, dermatologists, surgeons, general practitioners and health professionals with an interest in skin cancer, as well as physicians in training.
A 20% discount off the RRP for the text ‘Pathology of Melanocytic Tumours’ will be available to all attendees.
- Prof Klaus Busam, Director of Dermatopathology, Memorial Sloan Kettering Cancer Center, New York
- Prof Pedram Gerami, Dermatology, Northwestern University, Illinois
- Prof Richard Scolyer, Senior Staff Specialist of Tissue Pathology and Diagnostic Oncology at Royal Prince Alfred Hospital, Melanoma Institute Australia and The University of Sydney
- Dr Kerry Crotty, Kossard Pathology
- A/Prof Anne Cust, Melanoma Institute Australia, The University of Sydney
- Dr Peter Ferguson, Royal Prince Alfred Hospital, Melanoma Institute Australia and , The University of Sydney
- A/Prof Rooshdiya Karim, Royal Prince Alfred Hospital, and The University of Sydney
- Prof Georgina Long, Melanoma Institute Australia, The University of Sydney and Royal North Shore Hospital
- Dr Annabelle Mahar, Royal Prince Alfred Hospital
- Dr Catriona McKenzie, Royal Prince Alfred Hospital, and The University of Sydney
- Prof Scott Menzies, The University of Sydney and Royal Prince Alfred Hospital
- Prof Sandra O’Toole, Australian Clinical Laboratories
- Prof John Thompson, Melanoma Institute Australia, The University of Sydney and Royal Prince Alfred Hospital
- Dr Victor Tron, St. Michael’s Hospital, Toronto Canada
- Dr Robert Rawson, Royal Prince Alfred Hospital, Melanoma Institute Australia and The University of Sydney
Day 1 – Friday 14th February 2020
7:30 – 8:25: REGISTRATION (coffee and tea provided)
8:25 – 8:30: Welcome – Richard Scolyer
8:30 – 8:50: Acquired nevi including dysplastic naevi & special site naevi – Pedram Gerami
8:55 – 9:15: Blue naevi & related tumours – Klaus Busam
9:20 – 9:40: Combined naevi including deep penetrating naevi and BAP1 inactivated naevi – Richard Scolyer
9:45 – 10:05: Spitz nevi and atypical Spitz tumors – Klaus Busam
10:10 – 10:30: WHO Classification of basal cell carcinoma & implications for patient care – Catriona McKenzie
10:30 – 11:00: MORNING TEA
11:00 – 11:20: Borderline melanocytic tumours – Richard Scolyer
11:25 – 11:45: Immunohistochemistry – Klaus Busam
11:50 – 12:10: Cytogenetic analysis – Pedram Gerami
12:15 – 12:35: Mutation analysis – Sandra O’Toole
12:40 – 1:00: Gene expression studies – Pedram Gerami
1:00 – 2:00: LUNCH
2:00 – 2:20: Dermoscopy for pathologists – Kerry Crotty
2:25 – 2:45: Cooperation between surgeons & pathologists – John Thompson
2:50 – 3:05: Sentinel node biopsy pathology – Richard Scolyer
3:10 – 3:30: Melanoma facts & figures – Anne Cust
3:30 – 4:00: AFTERNOON TEA
4:00 – 4:20: Do patients understand pathology reports? Do clinicians?? – Better communication to improve care – Victor Tron
4:20 – 4:40: Congenital naevi and proliferative nodules – Pedram Gerami
4:40 – 5:00: Drug therapies for melanoma- what a pathologist needs to know – Georgina Long
5:00 – 5:20: Cutaneous and other reactions to new melanoma drug therapies – Rooshdiya Karim
5:20 – 5:40: Regression and tumoural melanosis – Peter Ferguson
5:40 – 6:00: Melanoma margins assessment – Klaus Busam
Day 2 – Saturday 15th February 2020
8:30 – 8:50: Acral and subungual pigmented tumours – Peter Ferguson
8:55 – 9:15: Genital & mucosal melanocytic tumours – Rob Rawson
9:20 – 9:40: Desmoplastic melanoma – Klaus Busam
9:45 – 10:05: Naevoid melanoma – Richard Scolyer
10:10 – 10:30: Spitzoid melanoma – Pedram Gerami
10:30 – 11:00: MORNING TEA
11:00 – 11:20: Cutaneous soft tissue tumours – Annabelle Mahar
11:20 – 11:45: Lentigo maligna pathology – Robert Rawson
11:40 – 11:55: Lentigo maligna treatment – Scott Menzies
11:55 – 12:20: Melanoma prognosis, staging & pathology reporting – Richard Scolyer
12:20 – 12:40: Blue naevus-like melanoma – Klaus Busam
12:40 – 1:00: Melanoma in children & adolescents – Pedram Gerami
1:00 – 1:20: Pigmented epitheloid melanocytoma – Richard Scolyer
1:20 – 2:10: LUNCH
2:10 – 2:50: Case presentations 1-5 – Pedram Gerami
2:50 – 3:30: Case presentations 6-10 – Klaus Busam
3:30 – 4:10: Case presentations 10-16 – Richard Scolyer, Rob Rawson & Peter Ferguson
Local accommodation options are listed below. Alternatively, the distance from the Sydney CBD to Camperdown is around 5km, or a 20-30 minute car ride.